Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > P2i raises £4.1m/$6.7m to exploit opportunities in nano-coating technology worldwide

Abstract:
P2i Ltd, the world leader in liquid-repellent nano-coating technology, has raised £4.1 million ($6.7 million), from new and existing shareholders, to support its accelerating commercialisation and international growth.

P2i raises £4.1m/$6.7m to exploit opportunities in nano-coating technology worldwide

London, UK | Posted on July 20th, 2009

P2i was established in 2004 to commercialise liquid-repellent treatments developed by the Ministry of Defence. Its revolutionary technology helps customers protect and improve a wide and growing range of products including performance textiles (such as hiking and military boots; running and golf shoes), hearing aids, laboratory consumables such as pipette tips, and a wide range of filtration products.

This Series C funding round comes as the company accelerates its growth across a wide range of markets. New investor Swarraton Partners led the round and, along with Naxos Capital Partners, provided most of the funds. Existing shareholder Unilever Ventures also participated in the round.

Carl Francis, P2i's Chief Executive, commented:

"This substantial new investment, particularly in light of today's tough fundraising environment, is a clear endorsement of our leading position in liquid-repellent nano-coating technology.

"It will enable us to exploit the international and multi-market potential for P2i and underpins our ability to work on an equal footing with some of the world's leading industrial, scientific and consumer brand players."

On his new shareholders, Mr Francis added "We are delighted to bring high quality investors such as Swarraton and Naxos on board. All of our shareholders, which include Porton Capital, Unilever Ventures, and Ploughshare Innovations, have great track records in helping companies like ours realise their full potential."

Stephen Brooke, Swarraton's Managing Partner, said:

"At Swarraton, we back companies with world class technology, solid management, and the potential to make a big impact in large markets. P2i is a perfect fit for us."



The new money will be invested in four main areas:

* operational infrastructure and facilities;
* marketing and sales capacity, including further development of the company's US organisation;
* capital equipment; and
* R&D.



Part of the manufacturing expenditure will be devoted to the development of patented continuous plasma-processing systems supporting higher-volume applications of P2i's technology, opening up fresh business opportunities, particularly in textiles, apparel, and FMCG products.

P2i's liquid-repellent nano-coating process has already been successfully applied to a wide range of products and markets, but holds the potential for further commercialisation in many more - for example in engineered textiles, protective gloves, hospital gowns and wound care, plus industrial lenses and solar cells.

In consumer sectors the presence of P2i's technology is indicated by its consumer brand, ion-maskô, now available in premium products from Ecco, Hi-TEC, Van Dal and leading uniform/workwear boot brand MAGNUM. P2i is also in discussions with a number of other world leading footwear brands, as well as several premium-brand sunglass manufacturers.

####

About P2i Ltd
How P2iís technology works

P2iís technology works by applying a nanometre-thick polymer layer over the entire surface of a product. Using an ionised gas (plasma) this layer is molecularly bound to the surface and will not leach away. The process confers superior oil and water repellency by reducing the surface energy to ultra-low levels Ė down to one third that of PTFE (polytetrafluoroethylene). In footwear and textile applications, P2iís technology also minimises liquid absorption from outside elements and evaporated perspiration.

For more information, please click here

Contacts:
College Hill:
Andrew Vincent
+44(0)1869 353812

Zoe March
+44(0)1869 353805

Copyright © P2i Ltd

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp. to Provide Live Remote Access to Its Annual Meeting of Shareholders on June 12, 2018 June 12th, 2018

180 Degree Capital Corp. Reports Net Asset Value per Share of $2.60 as of December 31, 2017; A Decrease of 3.0% From Prior Quarter and an Increase of 11.1% From December 31, 2016 February 27th, 2018

Nanowire LED Innovator Aledia Announces Ä30 ($36M) Million Series-C Financing: Intel Capital Joins Existing Investors to Commercialize Certain Nanowire-LED Technologies for Mobile Displays January 29th, 2018

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

Materials/Metamaterials

How a tetrahedral substance can be more symmetrical than a spherical atom: A new type of symmetry September 14th, 2018

Peering into private life of atomic clusters -- using the world's tiniest test tubes September 6th, 2018

Cannibalistic materials feed on themselves to grow new nanostructures September 1st, 2018

Environmentally friendly photoluminescent nanoparticles for more vivid display colors: Osaka University-led researchers created a new type of light-emitting nanoparticle that is made of ternary non-toxic semiconductors to help create displays and LED lighting with better colors t August 29th, 2018

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project